BE-Study design recommendations from regulatory authorities [Design Issues]

posted by Essar – 2006-08-22 11:07 (7238 d 08:31 ago) – Posting: # 235
Views: 8,104

Dear All,

Greetings!

Just as we receive recommendations from Office of Generic Drugs (OGD) of US-FDA regarding which BE study design to be followed and what in-vitro dissolution criteria to be adopted, does any regulatory authority in EU provides similar recommendations?

Request you to please provide your inputs.

Regards,
Essar

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
122 visitors (0 registered, 122 guests [including 19 identified bots]).
Forum time: 19:38 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5